Remove 2022 Remove Pharmaceutical products Remove Safety
article thumbnail

EMA publishes updated Q&A for ICH M10

European Pharmaceutical Review

These concentration measurements are used as part of regulatory decisions regarding the safety and efficacy of medicinal products. The US Food and Drug Administration (FDA) implementation date was 7 November 2022. The post EMA publishes updated Q&A for ICH M10 appeared first on European Pharmaceutical Review.

article thumbnail

Sustainable pharma packaging: breaking down the barriers to adoption

European Pharmaceutical Review

However, for the pharmaceutical industry, the challenge is not as simple as just switching materials. An industry that is among the world’s biggest polluters is caught in a balancing act between satisfying the health and safety demands of industry regulators and meeting the needs of modern eco-conscious consumers.

Pharma 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

RFID: The future of smart labelling?

Pharmaceutical Technology

Various uses soon became apparent including those for supply chain management, anti-counterfeiting, and to improve patient safety. In August of 2022, Fresenius Kabi announced a three-year plan to add GS1 Data Matrix barcodes, also known as 2D barcodes, to its US pharmaceutical portfolio.

article thumbnail

Elevating pharmaceutical manufacturing processes with real-time insights

European Pharmaceutical Review

To address these issues, companies should adopt more advanced production strategies such as continuous flow chemistry, as they can shorten manufacturing processes, increase productivity and throughput. The result is efficient, cost-effective and high-quality (bio)pharmaceutical production. principles.

article thumbnail

Tackling fake pharmaceuticals: an industry united against counterfeit products

European Pharmaceutical Review

Plus, as these security assets are invisibly coded, they allow for prime packaging real estate to be spent on further safety information, representing a potential opportunity for greater awareness and education around falsified medicines. . 2022 Jun 1 [cited 2022 Apr 1];3:100240. Supply-chain visibility. A united front.

article thumbnail

PharmaLab Congress 2024 – what’s new for the third year in Düsseldorf/Neuss

European Pharmaceutical Review

This year, PharmaLab Congress will be offering a diverse programme to professionals from analytical and microbiological quality control in the pharmaceutical industry, from contract laboratories, authorities and service providers. In 2022 and 2023, PharmaLab attracted more participants to Düsseldorf/Neuss than ever before.

article thumbnail

Developing point-of-care CAR T manufacturing

European Pharmaceutical Review

Second, the production and delivery of CAR T cells necessitates close collaboration between the pharma industry and academic (usually transplant) departments. 10 Benefits of point-of-care CAR T-cell therapy Even after validation of the efficacy and safety of the therapy, two critical challenges remained – affordability and accessibility.